Search research articles
Contact Us
Filters
Showing results (131-140 of 133) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 133 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1997
Prospective randomized placebo-controlled study of granulocyte-macrophage colony-stimulating factor without stem-cell transplantation after high-dose melphalan in patients with multiple myeloma
P Moreau, D Fiere, W R Bezwoda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 4, 2001
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus
S Ascioglu, J H Rex, B de Pauw, et al.
Bone Marrow Transplantation
|
May 1, 1996
The treatment of chronic myelogenous leukemia by interferon and cytosine-arabinoside: rational and design of the French trials. French CML Study Group
F Guilhot, A Guerci, D Fiere, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 133) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 133 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1997
Prospective randomized placebo-controlled study of granulocyte-macrophage colony-stimulating factor without stem-cell transplantation after high-dose melphalan in patients with multiple myeloma
P Moreau, D Fiere, W R Bezwoda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 4, 2001
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus
S Ascioglu, J H Rex, B de Pauw, et al.
Bone Marrow Transplantation
|
May 1, 1996
The treatment of chronic myelogenous leukemia by interferon and cytosine-arabinoside: rational and design of the French trials. French CML Study Group
F Guilhot, A Guerci, D Fiere, et al.
Page
of 14